Aprepitant API Market Report – Research, Industry Analysis Reports and Market Demands

Global Aprepitant API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Aprepitant API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥99%
- 1.3.3 Purity<99%
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Aprepitant API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Injection
- 1.4.3 Capsule
- 1.4.4 Emulsion
- 1.4.5 Oral Suspension
1.5 Global Aprepitant API Market Size & Forecast
- 1.5.1 Global Aprepitant API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Aprepitant API Sales Quantity (2020-2031)
- 1.5.3 Global Aprepitant API Average Price (2020-2031)

2 Manufacturers Profiles

3 Competitive Environment: Aprepitant API by Manufacturer

3.1 Global Aprepitant API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Aprepitant API Revenue by Manufacturer (2020-2025)
3.3 Global Aprepitant API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Aprepitant API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Aprepitant API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Aprepitant API Manufacturer Market Share in 2024
3.5 Aprepitant API Market: Overall Company Footprint Analysis
- 3.5.1 Aprepitant API Market: Region Footprint
- 3.5.2 Aprepitant API Market: Company Product Type Footprint
- 3.5.3 Aprepitant API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Aprepitant API Market Size by Region
- 4.1.1 Global Aprepitant API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Aprepitant API Consumption Value by Region (2020-2031)
- 4.1.3 Global Aprepitant API Average Price by Region (2020-2031)
4.2 North America Aprepitant API Consumption Value (2020-2031)
4.3 Europe Aprepitant API Consumption Value (2020-2031)
4.4 Asia-Pacific Aprepitant API Consumption Value (2020-2031)
4.5 South America Aprepitant API Consumption Value (2020-2031)
4.6 Middle East & Africa Aprepitant API Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Aprepitant API Sales Quantity by Type (2020-2031)
5.2 Global Aprepitant API Consumption Value by Type (2020-2031)
5.3 Global Aprepitant API Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Aprepitant API Sales Quantity by Application (2020-2031)
6.2 Global Aprepitant API Consumption Value by Application (2020-2031)
6.3 Global Aprepitant API Average Price by Application (2020-2031)

7 North America

7.1 North America Aprepitant API Sales Quantity by Type (2020-2031)
7.2 North America Aprepitant API Sales Quantity by Application (2020-2031)
7.3 North America Aprepitant API Market Size by Country
- 7.3.1 North America Aprepitant API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Aprepitant API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Aprepitant API Sales Quantity by Type (2020-2031)
8.2 Europe Aprepitant API Sales Quantity by Application (2020-2031)
8.3 Europe Aprepitant API Market Size by Country
- 8.3.1 Europe Aprepitant API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Aprepitant API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Aprepitant API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Aprepitant API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Aprepitant API Market Size by Region
- 9.3.1 Asia-Pacific Aprepitant API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Aprepitant API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Aprepitant API Sales Quantity by Type (2020-2031)
10.2 South America Aprepitant API Sales Quantity by Application (2020-2031)
10.3 South America Aprepitant API Market Size by Country
- 10.3.1 South America Aprepitant API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Aprepitant API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Aprepitant API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Aprepitant API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Aprepitant API Market Size by Country
- 11.3.1 Middle East & Africa Aprepitant API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Aprepitant API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Aprepitant API Market Drivers
12.2 Aprepitant API Market Restraints
12.3 Aprepitant API Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Aprepitant API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aprepitant API
13.3 Aprepitant API Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Aprepitant API Typical Distributors
14.3 Aprepitant API Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Aprepitant API market size was valued at US$ 436 million in 2024 and is forecast to a readjusted size of USD 587 million by 2031 with a CAGR of 4.4% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Aprepitant API, or Aprepitant Active Pharmaceutical Ingredient, is the core component of medications used to prevent nausea and vomiting, especially those associated with cancer chemotherapy, radiation therapy, and certain surgical procedures. Aprepitant itself is a substance that acts as a selective antagonist of the human substance P and neurokinin 1 (NK1) receptor in the central nervous system. The API is the pure form of this active compound, carefully synthesized and purified to meet strict pharmaceutical standards. Through a precise manufacturing process, the Aprepitant API is produced with a specific chemical structure and properties that enable it to interact with the relevant biological targets in the body. When formulated into pharmaceutical products, such as tablets or capsules, the Aprepitant API is combined with other inactive ingredients (excipients) to ensure proper dosage, stability, and ease of administration, ultimately providing effective antiemetic treatment to patients in need.
The Aprepitant API industry is currently experiencing notable trends. The market is on a growth trajectory, this growth is driven by the increasing global demand for anti - nausea drugs. Aprepitant is crucial in treating nausea and vomiting in patients undergoing chemotherapy, radiation therapy, and surgery, and its expanding applications have led to a growing demand for its API. Technological innovation is also a key trend. There have been continuous advancements in drug formulation, such as the development of more convenient oral formulations and extended - release versions, which improve patient compliance and therapeutic outcomes. In terms of production technology, manufacturers are constantly optimizing processes to enhance efficiency and reduce costs. Furthermore, the industry is seeing increasing strategic cooperation and mergers and acquisitions. API manufacturers are partnering with finished drug producers to ensure a stable supply of Aprepitant API, improve manufacturing processes, and enhance the distribution of Aprepitant - based medications. Some pharmaceutical companies are also strengthening their market positions through mergers and acquisitions. Regionally, the Asia - Pacific region is expected to witness the highest growth in the Aprepitant API market due to the expanding healthcare infrastructure and the rising incidence of cancer in countries like China and India. North America and Europe are also significant markets, driven by a high number of cancer cases, high healthcare expenditure, and advanced oncology treatments.
This report is a detailed and comprehensive analysis for global Aprepitant API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aprepitant API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Aprepitant API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Aprepitant API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Aprepitant API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aprepitant API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aprepitant API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jubilant Pharmova Limited, Piramal Pharma, Hetero, Dr. Reddy’s Laboratories, Inke, Viwit Pharmaceuticals Limited, Sichuan Qingmu Pharmaceutical Co., Ltd, Wisdom Pharmaceutical Co., Ltd., Solara Active Pharma Sciences, Pharmathen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aprepitant API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Injection
Capsule
Emulsion
Oral Suspension
Major players covered
Jubilant Pharmova Limited
Piramal Pharma
Hetero
Dr. Reddy’s Laboratories
Inke
Viwit Pharmaceuticals Limited
Sichuan Qingmu Pharmaceutical Co., Ltd
Wisdom Pharmaceutical Co., Ltd.
Solara Active Pharma Sciences
Pharmathen
Shandong Anxin Pharmaceutical Co., Ltd
Lianyungang Runzhong Pharmaceutical Co., Ltd
Chemcopia Ingredients Pvt Ltd
JL Pharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aprepitant API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aprepitant API, with price, sales quantity, revenue, and global market share of Aprepitant API from 2020 to 2025.
Chapter 3, the Aprepitant API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aprepitant API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Aprepitant API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aprepitant API.
Chapter 14 and 15, to describe Aprepitant API sales channel, distributors, customers, research findings and conclusion.

Buy now